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doi:10.1016/j.jfma.2011.05.014Background/Purpose: The pathophysiology of female lower urinary tract symptoms (LUTS) may
involve bladder, urethral, and pelvic floor dysfunctions. This study analyzed the relationship
between clinical symptoms and lower urinary tract dysfunctions (LUTD) in women.
Methods: A total of 1605 consecutive women were included. LUTS were classified as storage,
voiding, pain, and postmicturition symptoms. All patients underwent videourodynamic study
(VUDS) and the final diagnosis of LUTD was made based on VUDS findings. Patients were strat-
ified into three major disorder groups: sensory, motor, and bladder outlet disorders. The main
symptoms and associated symptoms were used for analysis in varying LUTD.
Results: Normal tracing was found in 272 patients (16.9%), sensory bladder disorders in 459
(28.6%), motor bladder disorders in 560 (34.9%), and bladder outlet disorders were found in
314 patients (19.6%). Frequent urination was the main symptom in patients with normal, bladder
oversensitivity, interstitial cystitis, and idiopathic detrusor overactivity (DO). In patients with
voiding dysfunction due to detrusor underactivity, bladder neck dysfunction and urethral stric-
ture, dysuria was the most common symptom. However, 707 (44%) of overall women had both
storage and voiding symptoms. DOwas present in 533women and in 149 (66%) of 212 with bladder
outlet obstruction. However, DO was only found in 42.5% of women with urgency and in 69.4% of
women with urgency incontinence based on reported LUTS.
Conclusion: Storage and voiding symptoms are common in women with LUTD. The differential
diagnosis of LUTD in women cannot be based on LUTS alone.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.zu Chi General Hospital, 707
970, Taiwan.
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ight ª 2012, Elsevier Taiwan LLCIntroduction
Lower urinary tract symptoms (LUTS) are symptoms repor-
ted by patients’ perception of bladder feeling. The real
pathophysiology for LUTS might be difficult to interpret
based on symptoms alone. Previous studies on female LUTS& Formosan Medical Association. All rights reserved.
Clinical symptoms in female LUTD 387have focused on overactive bladder syndrome (OAB), and
most physicians always prescribe antimuscarinics as the
first line treatment for women with symptoms of frequency
and urgency. Although the International Continence Society
(ICS) has made a clear definition between urgency and
increased bladder sensation,1 patients might not able to
differentiate between these two symptoms.
As in men, LUTS in women also include storage, voiding,
pain, and postmicturition symptoms. The pathophysiology
of female LUTS may also involve bladder, urethral, and
pelvic floor disorders. Therefore, it is essential to clearly
differentiate among different underlying urethrovesical
dysfunctions before giving appropriate treatment.
Videourodynamic study (VUDS) provides comprehensive
investigation of lower urinary tract dysfunction (LUTD). By
combining pressure flow, uroflow, and image studies, we
can identify LUTD according to the VUDS findings. Patients
with bladder neck dysfunction (BND), dysfunctional voiding
(DV), and bladder outlet obstruction (BOO) can also be
found in addition to the bladder disorders.
This retrospective study analyzed VUDS data from
a large cohort of women with LUTS to evaluate the corre-
lation between clinical symptoms and the underlying LUTD.Patients and methods
A total of 1605 consecutive women who had undergone the
first time VUDS for LUTS during the period August 1996 to
July 2010 were included. Patients with chronic urinary
retention, chronic urinary tract infection (UTI), urodynamic
stress urinary incontinence, pelvic organ prolapse, frank
neurogenic voiding dysfunction (NVD), previous lower
urinary tract surgery, or a previously established diagnosis
of interstitial cystitis/painful bladder syndrome (IC/PBS) or
genitourinary tract malignancy were excluded from the
analysis.
LUTS were carefully recorded. The main symptom was
defined as the most bothersome symptom among all LUTS.
Three other LUTS were also recorded as associated symp-
toms. The LUTS were classified as storage symptoms
[frequency, urgency, urgency urinary incontinence (UUI),
nocturia], voiding symptoms (dysuria, hesitancy, slow
stream, intermittency, straining to void, urinary retention),
pain symptoms (bladder pain, urethral pain, perineal pain),
and postmicturition symptoms (terminal dribble, feeling of
incomplete emptying, postmicturition leakage). Patients
with urgency and UUI, as reported on a 3-day voiding diary,
were defined as having OAB. Methods, definitions and units
conform to the standards jointly recommended by the ICS
and the International Urogynecological Association, except
where specifically noted.2
VUDS was performed using a multichannel urodynamic
system (Life-Tech, Stafford, TX, USA) and a C-arm fluoro-
scope (Toshiba, Tokyo, Japan). VUDS was performed before
any treatment was given. The patient was positioned in the
supine position and a 6-Fr dual-channel urethral catheter
was inserted transurethrally to record intravesical pressure
and an 8-Fr rectal balloon catheter was used to record the
intra-abdominal pressure. VUDS was performed by infusion
of warmed normal saline containing 20% Urografin at
a filling rate of 30 ml/minute in a sitting position. TheC-arm fluoroscope was positioned 45 from the buttocks so
that the urethra could be lengthened and the bladder neck,
urethral sphincer, and distal urethra could be clearly
identified. VUDS was repeated if abnormal findings were
noted during the first examination. The potassium chloride
(KCl) test using 0.4 M KCl solution was performed if patients
presented with IBS during the urodynamic study.3
A voiding detrusor pressure of more than 35 cm H2O was
defined as high voiding pressure; 10e35 cm H2O was defined
as normal voiding pressure, and lower than 10 cm H2O was
defined as low voiding pressure. Patients with high or
normal voiding pressure and those with low voiding pres-
sure and a normal flow rate were considered having normal
detrusor contractility, while those with a low voiding
pressure and low flow rate and/or large postvoid residual
[(PVR) more than 150 ml] volumes were considered to have
low detrusor contractility. Bladder compliance at bladder
capacity was measured by dividing the change in cysto-
metric volume by the change in detrusor pressure.
If patients had a strong desire to void at a cystometric
bladder capacity (CBC) of less than 350 ml and without
occurrence of DO, they were considerecd to have bladder
oversensitivity. When bladder pain was elicited during
bladder filling and the KCl test showed a positive result, the
finding was suggestive of IC/PBS. If patients did not have
a sensation of normal bladder fullness at a bladder capacity
of more than 500 ml, they were considered to have reduced
bladder sensation.
Bladder outlet conditions included BND, DV, urethral
stricture, and poor pelvic floor relaxation. BND was diag-
nosed if VUDS revealed a narrow bladder neck together
with high or normal detrusor contractility.4 When VUDS
showed a high voiding pressure, open bladder neck, and
a narrow midurethra during the voiding phase, DV due to
urethral sphincter uncoordination was considered.5 If
patients had a narrow distal urethra and a low flow rate
regardless of high or normal voiding pressure, they were
considered to have a urethral stricture. Patients who could
not adequately relax their pelvic floor muscles and in whom
VUDS showed a low voiding pressure and intermittent flow
pattern were considered to have poor relaxation of the
pelvic floor muscles (PRPF).6
DO was defined as urodynamic evidence of spontaneous
detrusor contractions occurring during bladder filling
(phasic DO) or occurring before uninhibited detrusor
contraction voiding at bladder capacity (terminal DO).1,2 If
the DO was associated with incomplete bladder emptying
and PVR of more than 100 ml, detrusor hyperactivity and
impaired contractility (DHIC) was considered.7 Patients
with DO without BOO or DHIC were considered to have
idiopathic DO (IDO). If patients did not have a voiding
detrusor contractility of more than 10 cm H2O and needed
to void by abdominal straining or were unable to void,
detrusor underactivity (DU) was diagnosed.
The final diagnosis of LUTD was made based on the main
VUDS findings and clinical characteristics. According to the
VUDS results, patients were stratified into three major
disorder groups: sensory, motor, and bladder outlet disor-
ders. The main symptoms and at most three associated
symptoms were used for analysis of their association with
LUTD. The urodynamic parameters (CBC, Pdet, Qmax, PVR
volume, and bladder compliance) were analyzed and
Table 1 Classification of female lower urinary tract
symptoms by videourodynamic study.
Normal findings 272 (16.9%)
Sensory disorders (459)
Bladder oversensitivity 289 (18.0%)
Suggestive of interstitial cystitis/painful
bladder syndrome
170 (10.6%)
Motor disorders (560)
Idiopathic detrusor overactivity 308 (19.2%)
DO and impaired contractility 69 (4.3%)
Detrusor underactivity 183 (11.4%)
Bladder outlet disorders (314)
Bladder neck dysfunction 27 (1.7%)
Dysfunctional voiding 168 (10.5%)
Urethral stricture 17 (1.1%)
Poor relaxation of pelvic floor muscles 102 (6.4%)
388 H.-C. Kuocompared among all female LUTD subgroups. Statistical
analysis was performed by analysis of variance (ANOVA)
among different LUTD subgroups. A p value of less than 0.05
was considered significant.
Results
Table 1 lists the definitive diagnoses based on VUDS results
in the 1605 women. Normal tracing was found in 272
patients (16.9%), sensory bladder disorders in 459 (28.6%),
motor bladder disorders in 560 (34.9%), and bladder outlet
disorders were found in 314 patients (19.6%). The patients
ranged in age from 18e98 years (mean, 58 years). There
was no significant difference in mean age or age distribu-
tion among the subgroups (pZ 0.440).
Table 2 shows the main clinical symptoms in all LUTD.
Frequent urination was the primary symptom in patients
with normal function, bladder oversensitivity, IC/PBS, and
IDO. In addition, dysuria was also noted among the first
three main symptoms in these women. In women with
voiding dysfunction such as DV and PRPF, frequent urination
remained the most common symptom (41.1% and 52%,
respectively), and dysuria was the second most prevalentTable 2 Main symptoms of female lower urinary dysfunction.
Main symptom of LUTD
Normal (272) Frequency 100 (36.8%) Dy
BO (289) Frequency 127 (43.9%) Dy
IC/PBS (170) Frequency 97 (57.0%) Bla
IDO (308) Frequency 138 (44.8%) UU
DHIC (69) UUI 25 (36.2%) Dy
DU (183) Dysuria 119 (65.0%) Fre
DV (168) Frequency 69 (41.1%) Dy
BND (27) Dysuria 17 (63.0%) UU
US (17) Dysuria 8 (47.1%) Fre
PRPF (102) Frequency 53 (52.0%) Dy
BNDZ bladder neck dysfunction; BOZ bladder oversensitivity; DHICZ
underactivity; DVZ dysfunctional voiding; IC/PBSZ interstitial cyst
activity; PRPFZ poor relaxation of pelvic floor muscles; USZ urethrmain symptom (32.1% and 30.4%, respectively). In patients
with voiding dysfunction due to DU, BND and US, dysuria
was the most common symptom (86%, 63%, and 47.1%,
respectively), followed by frequent urination and UUI. UUI
was the most common symptom in patients with DHIC fol-
lowed by dysuria and urinary retention.
If we classified LUTS as comprising storage, voiding,
pain and postmicturition symptoms, all LUTD groups had
storage symptoms. Voiding symptoms were also highly
prevalent in women with voiding dysfunctions due to
bladder outlet disorders (DV, BND, US, and PRPF) or low
detrusor contractility (DHIC and DU). However, about 30%
of women with sensory disorders (bladder oversensitivity,
IC/PBS) or IDO still had voiding symptoms. The prevalence
of pain symptoms was higher in women with IC/PBS (68.8%)
but more than 20% of women with bladder oversensitivity
and PRPF also had pain symptoms. Postmicturition symp-
toms were not common in female LUTD except in women
with DU (Table 3).
Overall, frequency was the most common presented
LUTS (nZ 1528, 95.2%), followed by urgency (nZ 1108,
69%), dysuria, slow stream or urinary retention (nZ 801,
49.9%), UUI (nZ 425, 26.5%), and painful symptoms
(nZ 371, 23.2%). OAB dry (nZ 683) and OAB wet (nZ 425)
were widely distributed among women classified as being
normal (128 and 42, respectively), as well as those classi-
fied as having sensory (218 and 28, respectively), motor
(215 and 277, respectively), and bladder outlet disorders
(171 and 78, respectively). However, DO was only found in
42.5% of all women with urgency (OAB dry) and in 69.4% of
women with UUI (OAB wet).
Table 4 shows the combination of main and associated
LUTS in female LUTD. Most patients had both storage and
voiding symptoms, or storage symptoms alone, but only
a few patients had voiding symptoms alone. Patients with
IC/PBS presented with storage and pain symptoms (56.5%),
storage and voiding symptoms (14.7%), or storage symptoms
alone (16.5%), but none presented with pain symptoms
alone. Most of the patients with voiding disorders presented
with storage and voiding symptoms or storage symptoms
alone, but not with voiding symptoms alone.
The urodynamic parameters in these LUTD are shown in
Table 5. DO was present in 533 women, including 308 (100%)
IDO, 69 (100%) DHIC, 7 (4%) DU, and 149 (70.3%) women withsuria 54 (19.9%) SUI 25 (9.19%)
suria 79 (27.3%) Bladder pain 35 (12.1%)
dder pain 55 (32.4%) Dysuria 5 (2.9%)
I 107 (34.7%) Dysuria 58 (18.8)
suria 21 (30.4%) Urine retention 17 (24.6%)
quency 32 (17.5%) Urine retention 27 (14.8%)
suria 54 (32.1%) UUI 26 (15.5%)
I 6 (22.2%) Frequency 4 (14.8%)
quency 4 (23.5%) UUI 3 (17.6%)
suria 31 (30.4%) Bladder pain 11 (10.8%)
detrusor overactivity with impaired contractility; DUZ detrusor
itis/painful bladder syndrome; IDOZ idiopathic detrusor over-
al stricture; UUIZ urgency urinary incontinence.
Table 3 Occurrence of different lower urinary tract symptoms in different female lower urinary tract dysfunction.
Storage symptoms Voiding symptoms Pain symptoms Postmicturition symptoms
Normal (272) 272 (100.0%) 100 (36.8%) 78 (28.7%) 22 (8.09%)
BO (289) 289 (100.0%) 143 (49.5%) 80 (27.7%) 19 (6.57%)
IC/PBS (170) 170 (100.0%) 42 (24.7%) 117 (68.8%) 7 (4.12%)
IDO (308) 308 (100.0%) 111 (36.0%) 22 (7.1%) 4 (1.30%)
DHIC (69) 69 (100.0%) 55 (79.7%) 7 (10.1%) 1 (1.45%)
DU (183) 183 (100.0%) 177 (96.7%) 7 (3.8%) 73 (39.9%)
DV (168) 168 (100.0%) 87 (51.8%) 27 (16.17%) 5 (3.00%)
BND (27) 27 (100.0%) 20 (74.1%) 2 (7.4%) 0 (0.00%)
US (17) 17 (100.0%) 10 (58.8%) 3 (17.7%) 0 (0.00%)
PRPF (102) 102 (100.0%) 56 (54.9%) 29 (28.4%) 14 (1.73%)
Total (1605) 1605 (100.0%) 801 (49.9%) 372 (23.2%) 145 (9.03%)
BNDZ bladder neck dysfunction; BOZ bladder oversensitivity; DHICZ detrusor overactivity with impaired contractility; DUZ detrusor
underactivity; DVZ dysfunctional voiding; IC/PBSZ interstitial cystitis/painful bladder syndrome; IDOZ idiopathic detrusor over-
activity; PRPFZ poor relaxation of pelvic floor muscles; USZ urethral stricture; UUIZ urgency urinary incontinence.
Clinical symptoms in female LUTD 389bladder outlet obstruction (BOO), which comprised 116
(69%) with DV, 18 (67%) with BND, and 15 (88%) with US.
Among the 312 patients with bladder outlet disorders, 149
(48%) had DO. Bladder oversensitivity (160/212; 75%) and
DO (149/212; 70%) were noted in most of the patients with
BOO (DV, BND, US), whereas all patients with PRPF had
a stable bladder and normal detrusor contractility.
Among the 459 patients with bladder oversensitivity, 322
received the KCl test and a positive result was obtained in
165 (51%). Cystoscopy with hydrodistention was performed
and the diagnosis of IC/PBS was confirmed in 147 (89.1%).Discussion
This study analyzed VUDS-derived data on the underlying
urethrovesical dysfunctions in 1605 women with LUTS.
Storage and voiding symptoms were commonly found in
LUTD. Bladder sensory disorders were noted in 28.6% and
bladder outlet disorders were found in 19.6% of women
with LUTS. According to the final VUDS diagnosis, clinical
symptoms are not likely to be reliable in establishingTable 4 Combination of different lower urinary tract symptom
Main and associat
Storage alone Voiding alone Storage and
voiding
Normal (272) 96 (35.3%) 1 (0.4%) 97 (35.7%)
BO (289) 92 (31.9%) 1 (0.3%) 116 (40.3%)
IC/PBS(170) 28 (16.5%) 0 25 (14.7%)
IDO (308) 174 (56.5%) 0 112 (36.4%)
DHIC (69) 13 (18.8%) 0 49 (71.0%)
DU (183) 2 (1.1%) 23 (12.6%) 151 (82.5%)
DV (168) 55 (32.7%) 1 (0.6%) 84 (50.0%)
BND (27) 5 (18.5%) 0 20 (74.1%)
US (17) 4 (23.5%) 0 10 (58.8%)
PRPF (102) 29 (28.4%) 1 (1.0%) 43 (42.2%)
BNDZ bladder neck dysfunction; BOZ bladder oversensitivity; DHICZ
underactivity; DVZ dysfunctional voiding; IC/PBSZ interstitial cyst
activity; PRPFZ poor relaxation of pelvic floor muscles; USZ urethraa preliminary diagnosis or treatment strategy for women
with LUTS.
This study revealed that most of the patients with
sensory or motor bladder disorders presented with both
storage and voiding symptoms. The main symptoms of
patients with bladder oversensitivity, IC/PBS, IDO, DHIC
were frequency, urgency and UUI, although dysuria was not
an uncommon symptom. Because the bladder capacity in
the patients with sensory bladder disorders was significantly
smaller than that in normal women, it is possible that these
women experienced dysuria and slow stream during voiding
because of early bladder alertness at a small volume.
Women with bladder oversensitivity and IC/PBS
comprised 28.6% of all women with LUTD. It was interesting
to find that most of the women with IC/PBS or bladder
oversensitivity presented with frequency as their main
symptom. Although 32.4% of women with IC/PBS had
bladder pain as the main symptom, the symptom was also
noted in 12.1% of women with bladder oversensitivity.
Dysuria was the main symptom in 27.3% of women with
bladder oversensitivity, but was only experienced by 2.9%
of women with IC/PBS. Although high voiding pressures in female lower urinary tract dysfunction.
ed symptoms
Storage and pain Empty and pain Storage and voiding
and pain
63 (23.2%) 0 15 (5.5%)
48 (16.7%) 3 (1.0%) 28 (9.7%)
96 (56.5%) 0 21 (12.4%)
20 (6.5%) 0 2 (0.6%)
1 (1.4%) 0 6 (8.7%)
0 0 7 (3.8%)
23 (13.7%) 0 5 (3.0%)
2 (7.4%) 0 0
3 (17.6%) 0 0
12 (11.8%) 0 17 (16.7%)
detrusor overactivity with impaired contractility; DUZ detrusor
itis/painful bladder syndrome; IDOZ idiopathic detrusor over-
l stricture; UUIZ urgency urinary incontinence.
Table 5 Urodynamic parameters in different female lower urinary tract dysfunction.
CBC (ml) Pdet (cmH2O) Qmax (ml/s) PVR (ml) Compliance (ml/cmH2O)
Normal 482.3 100.1 18.8 8.98 20.5 7.95 25.7 44.0 120.5 121.2
BO 281.2 86.0 19.0 9.73 13.0 7.04 36.7 65.4 71.3 73.8
IC/PBS 286.5 99.5 18.8 11.7 12.9 7.33 22.7 47.8 70.5 66.9
IDO 250.9 125.0 22.4 11.3 13.5 7.84 41.8 69.7 63.0 67.1
DHIC 294.7 110.0 12.6 7.1 6.3 4.45 188.3 110.0 62.5 69.7
DU 383.2 161.5 5.52 4.74 5.44 7.60 271.1 208.8 70.2 105.8
DV 285.7 159.7 49.1 17.4 11.3 7.56 77.4 112.6 63.0 82.1
BND 314.7 177.6 60.4 23.2 6.41 4.12 136.8 170.5 61.8 84.1
US 219.9 134.7 65.4 29.2 5.94 3.05 92.9 80.4 29.1 25.9
PRPF 353.3 133.5 20.8 9.94 9.95 5.78 96.0 90.1 84.7 78.3
BNDZ bladder neck dysfunction; BOZ bladder oversensitivity; CBCZ cystometric bladder capacity; DHICZ detrusor overactivity with
impaired contractility; DUZ detrusor underactivity; DVZ dysfunctional voiding; IC/PBSZ interstitial cystitis/painful bladder
syndrome; IDOZ idiopathic detrusor overactivity; PdetZ detrusor pressure; PRPFZ poor relaxation of pelvic floor muscles;
PVRZ postvoid residual; QmaxZmaximum flow rate; USZ urethral stricture; UUIZ urgency urinary incontinence.
390 H.-C. Kuosuggestive of BOO has been noted in patients with IC/PBS,8
we did not find this phenomenon in this study.
The KCl test was reported a reliable modality for
differentiating IC/PBS from bladder oversensitivity.3 A total
of 89.1% of women with IC/PBS had a positive KCl test and
the diagnosis of IC/PBS was further confirmed by cysto-
scopic hydrodistention. It seems rational to use this test to
identify urothelial dysfunction in all women with small
bladder capacity and bladder oversensitivity.
Although DO was highly prevalent in women with BOO
(66%), BOO was found in only 28% (149 of 532) of women
with DO. Most cases of BOO were due to DV (77.8%), sug-
gesting that functional BOO remained the most common
type of female BOO. Based on clinical symptoms, DO was
only found in 42.5% of women with urgency (OAB dry) and in
69.4% of women with UUI (OAB wet). These findings are
compatible with previous reports.9,10 Although most of the
women with LUTD complained of urgency and frequency as
their main symptom, the symptoms are likely the result of
bladder oversensitivity during filling rather than DO in
nature. This is also the possible cause for the different
objective urodynamic findings between OAB patients with
and those without DO.11
Urgency and frequency were highly prevalent in all LUTD
and in normal women. Patients usually reported urgency
only because they experienced an early voiding desire
without actually feeling that it was difficult to defer
urination. If self-reported urgency is considered to by
synonymous with OAB, then prevalence of OAB dry will be
very high in female LUTD. However, the incidence of DO
was low. On the other hand, UUI might reflect the real DO
condition in female LUTS in this study. Sensory urgency is
speculated to be part of the same spectrum of bladder
dysfunction as DO.12 The CBC in patients with IDO and BOO
was similar to that in patients with bladder oversensitivity
and IC/PBS, and most patients with BOO had an increased
bladder sensation during bladder filling, indicating that
sensory urgency is closely linked to DO. This finding also
reflects the possibility that overactive bladder is not only
overactive but also hypersensitive.13
Pelvic floor dysfunction involves the development of
hypertonic and dysfunctional muscles resulting in eliminationproblems, chronic pelvic pain, and voiding disorders.14
DV is a condition characterized by lack of coordination
between the urethral sphincter and detrusor during void-
ing.15 PRPF is a condition in which the pelvic floor muscles
fail to relax in initiation or during micturition. Although
these two LUTD are possibly due to different etiologies,
they may present similar symptoms. Storage symptoms are
even more common than voiding symptoms in women with
DV.5 We found that women with PRPF presented with both
storage and voiding symptoms. It is not easy to differentiate
between PRPF and DV without VUDS. The only differences
between them are higher incidence of DO in women with DV
and greater CBC in PRPF, suggesting that DV is a more severe
form of functional BOO due to urethral sphincter spasticity
than PRPF.
This study also revealed that PRPF was commonly found
in women with a low Qmax who presented with storage and
voiding symptoms. During VUDS, it is frequently observed
that a woman becomes a non-voider or needs to void with
the aid of abdominal straining.16 Therefore, free voiding
uroflowmetry is important to establish a diagnosis of PRPF.
Only in women with consistent uroflowmetry findings
between free uroflow and VUDS can a diagnosis of PRPF be
made. The Pdet of PRPF was normal and CBC was signifi-
cantly greater than that of female BOO, suggesting that
the voiding dysfunction among women with PRPF is prob-
ably due to poorly relaxed pelvic floor muscles but not
anatomic BOO.
All patients with BOO (DV, BND, US) had dysuria, fre-
quency, and UUI as main symptoms, although the severity
of these symptoms differed among them. Most of the
women with DV (41.1%) and PRPF (52%) had frequency as
their main symptom, but the majority of women with BND
(63%) and US (47.1%) had dysuria as the main symptom. This
difference in presenting symptoms between these
subgroups of patients with voiding dysfunction could be due
to different pathophysiology as well as to different func-
tional and anatomical bladder outlet disorders. Patients
with increased urethral sphincter tone and pelvic floor
muscle hyperactivity not only have increased urethral
resistance but also increased bladder sensation or over-
activity through neuromodulation, resulting in different
Clinical symptoms in female LUTD 391types of urothelial dysfunction which might be elicited by
intravesical potassium instillation.17
Conclusion
This study revealed that LUTS in women involve several
different vesicourethral conditions. Storage and voiding
symptoms are common in female LUTD including sensory,
motor or bladder outlet disorders. The differential diag-
nosis of these LUTD cannot be based on LUTS alone.References
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